[Orphan drugs].

Authors :: Kolár J
Chalabala M
Srámková H
Source :: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti [Ceska Slov Farm] 2001 Mar; Vol. 50 (2), pp. 59-65.
Publication Year :: 2001
Abstract: The paper discusses the problems of orphan drugs from the standpoint of the attitude of state authorities in the USA, Japan, and particularly Europe (the European Union) to their definition and the formation of appropriate legislation--financial provision for the development, production, provision of exclusive sale rights--which warranties the availability of the drug to every patient suffering from a rare disease.

Subjects :: Drug Industry legislation & jurisprudence
European Union
Japan
United States
Health Policy
Orphan Drug Production economics
Orphan Drug Production legislation & jurisprudence

Language :: Czech
ISSN :: 1210-7816
Volume :: 50
Issue :: 2
Database :: MEDLINE
Journal :: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti
Publication Type :: Academic Journal
Accession number :: 11288591

Tools